BREAST SURGERY · LIV ULUS
Assoc. Prof. MD. Selman Emiroğlu
Associate Professor of General Surgery · Liv Hospital Ulus
Assoc. Prof. Dr. Selman Emiroğlu is a breast and surgical-oncology specialist at Liv Hospital Ulus. He earned his English-medium MD at Marmara University, completed general surgery training at Istanbul University Faculty of Medicine, and is currently a PhD candidate in Molecular and Medical Genetics at Biruni University. He has performed over 2,000 breast surgeries, sits on the board of the Turkish Federation of Breast Diseases Societies, and has been recognised at three national surgical congresses.
2000+
breast surgeries performed
30+
peer-reviewed publications
6
h-index
Breast SurgeryOncoplastic SurgerySurgical OncologyMastectomyLaparoscopic SurgeryBreast Cancer Genetics
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR
Turkish
· native
EN
English
· professional
RU
Russian
· via BergemHealth coordinator
UK
Ukrainian
· via BergemHealth coordinator
ISTANBUL · 05/2026
AWARDS & RECOGNITION
-
★2023Second Prize for Oral Presentation11th Surgical Research Congress
-
2022First Prize for Oral Presentation22nd National Surgical Congress
-
2019First Prize for Oral PresentationTurkish Federation of Breast Diseases Associations 15th National Congress
EDUCATION & CAREER
Timeline
Career milestones.
2008-2013
General Surgery Resident
Istanbul University Faculty of Medicine
2014-2016
General Surgery Specialist
Kırkağaç State Hospital, Manisa
2016-present
General Surgery Specialist
Istanbul University, Istanbul Faculty of Medicine
2023-present
General Surgery Specialist (faculty)
Biruni University Faculty of Medicine
current
Associate Professor / General Surgeon
Liv Hospital Ulus
PUBLICATIONS
Scientific work
Selected peer-reviewed publications.
-
2021Eur J Surg Oncol«Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02 study»· co-author
-
2020JCO Glob Oncol«Surgical trends in breast cancer in Turkey: an increase in breast-conserving surgery»· co-author
-
2024World J Surg Oncol«Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy»· co-author
-
2025JAMA Surg«De-escalation of nodal surgery in clinically node-positive breast cancer»· co-author
-
2025Clin Breast Cancer«Omitting axillary dissection in triple-negative and HER2-overexpressed breast cancers with positive sentinel lymph nodes during upfront surgery: SENATURK-OTHELLO study»· co-author
-
2022Curr Med Imaging«Abbreviated and standard breast MRI in neoadjuvant chemotherapy response evaluation: a comparative study»· co-author
CLINIC
Where they practise
Direct contract with BergemHealth at every listed clinic.
REQUEST
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
OTHER DOCTORS
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.